Skip to main content
. Author manuscript; available in PMC: 2014 Oct 20.
Published in final edited form as: Cancer. 2009 Feb 1;115(3):531–539. doi: 10.1002/cncr.23956

Figure 1.

Figure 1

Forest plot of the study-specific (boxes) and summary (diamond) relative risk and 95% confidence intervals (lines) for ovarian cancer risk per five years of estrogen therapy use. The overall summary ovarian cancer risk per five years of estrogen therapy use is 1.22 (95% CI 1.18–1.27, p<0.0001). First author for each study is given on the vertical axis, together with the study reference number.

ET – estrogen-alone therapy.

RR – relative risk